SERZONE Drug Patent Profile

✉ Email this page to a colleague

When do Serzone patents expire, and what generic alternatives are available?

Serzone is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in SERZONE is nefazodone hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nefazodone hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Serzone

A generic version of SERZONE was approved as nefazodone hydrochloride by TEVA on September 16^th, 2003.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for SERZONE?
What are the global sales for SERZONE?
What is Average Wholesale Price for SERZONE?

Summary for SERZONE

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	103
Clinical Trials:	1
Patent Applications:	1,195
DailyMed Link:	SERZONE at DailyMed

Drug patent expirations by year for SERZONE

Recent Clinical Trials for SERZONE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Boston Medical Center	Phase 2
Boston University	Phase 2

See all SERZONE clinical trials

US Patents and Regulatory Information for SERZONE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bristol Myers Squibb	SERZONE	nefazodone hydrochloride	TABLET;ORAL	020152-001	Dec 22, 1994		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bristol Myers Squibb	SERZONE	nefazodone hydrochloride	TABLET;ORAL	020152-004	Dec 22, 1994		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bristol Myers Squibb	SERZONE	nefazodone hydrochloride	TABLET;ORAL	020152-002	Dec 22, 1994		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bristol Myers Squibb	SERZONE	nefazodone hydrochloride	TABLET;ORAL	020152-003	Dec 22, 1994		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for SERZONE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bristol Myers Squibb	SERZONE	nefazodone hydrochloride	TABLET;ORAL	020152-005	Dec 22, 1994	⤷ Sign Up	⤷ Sign Up
Bristol Myers Squibb	SERZONE	nefazodone hydrochloride	TABLET;ORAL	020152-002	Dec 22, 1994	⤷ Sign Up	⤷ Sign Up
Bristol Myers Squibb	SERZONE	nefazodone hydrochloride	TABLET;ORAL	020152-004	Dec 22, 1994	⤷ Sign Up	⤷ Sign Up
Bristol Myers Squibb	SERZONE	nefazodone hydrochloride	TABLET;ORAL	020152-006	Dec 22, 1994	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for SERZONE

See the table below for patents covering SERZONE around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Japan	S6036469	1,2,4-TRIAZOL-3-ONE ANTIDEPRESSANT	⤷ Sign Up
Japan	S57159774	ANTIDEPRESSANT OF 2-PHENOXYALKYL-1,2,4- TRIAZOLYL-3-ONE	⤷ Sign Up
Germany	69329942		⤷ Sign Up
United Kingdom	2184447	A SUBSTITUTED TRIAZOLONE	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for SERZONE

Recent Clinical Trials for SERZONE

Make Better Decisions: Try a trial or see plans & pricing